EEV Trademark

Trademark Overview

On Friday, November 22, 2019, a trademark application was filed for EEV with the United States Patent and Trademark Office. The USPTO has given the EEV trademark a serial number of 88702723. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 25, 2023. This trademark is owned by Entrada Therapeutics, Inc.. The EEV trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for human use, namely, pharmaceuticals for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes

Pharmaceutical research and development services

General Information

Serial Number88702723
Word MarkEEV
Filing DateFriday, November 22, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2020

Trademark Statements

Goods and ServicesPharmaceuticals for human use, namely, pharmaceuticals for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes
Goods and ServicesPharmaceutical research and development services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 30, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEntrada Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameEntrada Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Tuesday, November 26, 2019NEW APPLICATION ENTERED
Saturday, November 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 26, 2020ASSIGNED TO EXAMINER
Thursday, February 27, 2020NON-FINAL ACTION WRITTEN
Thursday, February 27, 2020NON-FINAL ACTION E-MAILED
Thursday, February 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 20, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 20, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 29, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 21, 2021SOU TEAS EXTENSION RECEIVED
Friday, May 21, 2021SOU EXTENSION 1 FILED
Friday, May 21, 2021SOU EXTENSION 1 GRANTED
Friday, May 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 27, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 27, 2021SOU EXTENSION 2 FILED
Wednesday, October 27, 2021SOU EXTENSION 2 GRANTED
Friday, October 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 14, 2022SOU EXTENSION 3 FILED
Thursday, April 14, 2022SOU EXTENSION 3 GRANTED
Saturday, April 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 28, 2022SOU EXTENSION 4 FILED
Wednesday, September 28, 2022SOU EXTENSION 4 GRANTED
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022ASSIGNED TO EXAMINER
Tuesday, April 18, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 18, 2023SOU EXTENSION 5 FILED
Monday, April 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 25, 2023SOU EXTENSION 5 GRANTED
Wednesday, April 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 25, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

pharmaceuticals nephrological diseases oncological genitourinary dermatological conditions ophthalmological mediated research